ELVNEnliven Therapeutics, Inc.
$41.50+91% 1Y
$41.50
$15.1452 weeks$61.15
Is the business good?
How good a business is ELVN?
- Share count, year on year
- +27%
Share count, year on year · shareholders own a smaller slice than a year ago
Details›
- Free cash flow, trailing twelve months
- −$67M
- Net income, trailing twelve months
- −$106M
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
On our screens:Most shorted stocks